Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma

Duk Choi Yoo, Seung Kim Ki, Sunhyo Ryu, Youngkyu Park, Hoon Cho Nam, Hee Rha Seo, June Jang Ja, Jae Y. Ro, Woo Juhng Sang, Chan Choi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Claudin-7 has recently been suggested to be a distal nephron marker. We tested the possibility that expression of claudin-7 could be used as a marker of renal tumors originating from the distal nephron. We examined the immunohistochemical expression of claudin-7 and parvalbumin in 239 renal tumors, including 179 clear cell renal cell carcinoma (RCC)s, 29 papillary RCCs, 20 chromophobe RCCs, and 11 renal oncocytomas. In addition, the methylation specific-PCR (MSP) of claudin-7 was performed. Claudin-7 and parvalbumin immunostains were positive in 3.4%, 7.8% of clear cell RCCs, 34.5%, 31.0% of papillary RCCs, 95.0%, 80.0% of chromophobe RCCs, and 72.7%, 81.8% of renal oncocytomas, respectively. The sensitivity and specificity of claudin-7 in diagnosing chromophobe RCC among subtypes of RCC were 95.0% and 92.3%. Those of parvalbumin were 80.0% and 88.9%. The expression pattern of claudin-7 was mostly diffuse in chromophobe RCC and was either focal or diffuse in oncocytoma. All of the cases examined in the MSP revealed the presence of unmethylated promoter of claudin-7 without regard to claudin-7 immunoreactivity. Hypermethylation of the promoter might not be the underlying mechanism for loss of its expression in RCC. Claudin-7 can be used as a useful diagnostic marker in diagnosing chromophobe RCC and oncocytoma.

Original languageEnglish
Pages (from-to)305-310
Number of pages6
JournalJournal of Korean medical science
Volume22
Issue number2
Publication statusPublished - 2007 Apr 1

Fingerprint

Renal Cell Carcinoma
Parvalbumins
Nephrons
Methylation
Oxyphilic Adenoma
Kidney
Polymerase Chain Reaction
Tumor Biomarkers
Renal oncocytoma
Sensitivity and Specificity
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Yoo, D. C., Ki, S. K., Ryu, S., Park, Y., Nam, H. C., Seo, H. R., ... Choi, C. (2007). Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. Journal of Korean medical science, 22(2), 305-310.
Yoo, Duk Choi ; Ki, Seung Kim ; Ryu, Sunhyo ; Park, Youngkyu ; Nam, Hoon Cho ; Seo, Hee Rha ; Ja, June Jang ; Ro, Jae Y. ; Sang, Woo Juhng ; Choi, Chan. / Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. In: Journal of Korean medical science. 2007 ; Vol. 22, No. 2. pp. 305-310.
@article{31a34abc152c474e98659f96c2dedde3,
title = "Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma",
abstract = "Claudin-7 has recently been suggested to be a distal nephron marker. We tested the possibility that expression of claudin-7 could be used as a marker of renal tumors originating from the distal nephron. We examined the immunohistochemical expression of claudin-7 and parvalbumin in 239 renal tumors, including 179 clear cell renal cell carcinoma (RCC)s, 29 papillary RCCs, 20 chromophobe RCCs, and 11 renal oncocytomas. In addition, the methylation specific-PCR (MSP) of claudin-7 was performed. Claudin-7 and parvalbumin immunostains were positive in 3.4{\%}, 7.8{\%} of clear cell RCCs, 34.5{\%}, 31.0{\%} of papillary RCCs, 95.0{\%}, 80.0{\%} of chromophobe RCCs, and 72.7{\%}, 81.8{\%} of renal oncocytomas, respectively. The sensitivity and specificity of claudin-7 in diagnosing chromophobe RCC among subtypes of RCC were 95.0{\%} and 92.3{\%}. Those of parvalbumin were 80.0{\%} and 88.9{\%}. The expression pattern of claudin-7 was mostly diffuse in chromophobe RCC and was either focal or diffuse in oncocytoma. All of the cases examined in the MSP revealed the presence of unmethylated promoter of claudin-7 without regard to claudin-7 immunoreactivity. Hypermethylation of the promoter might not be the underlying mechanism for loss of its expression in RCC. Claudin-7 can be used as a useful diagnostic marker in diagnosing chromophobe RCC and oncocytoma.",
author = "Yoo, {Duk Choi} and Ki, {Seung Kim} and Sunhyo Ryu and Youngkyu Park and Nam, {Hoon Cho} and Seo, {Hee Rha} and Ja, {June Jang} and Ro, {Jae Y.} and Sang, {Woo Juhng} and Chan Choi",
year = "2007",
month = "4",
day = "1",
language = "English",
volume = "22",
pages = "305--310",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

Yoo, DC, Ki, SK, Ryu, S, Park, Y, Nam, HC, Seo, HR, Ja, JJ, Ro, JY, Sang, WJ & Choi, C 2007, 'Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma', Journal of Korean medical science, vol. 22, no. 2, pp. 305-310.

Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. / Yoo, Duk Choi; Ki, Seung Kim; Ryu, Sunhyo; Park, Youngkyu; Nam, Hoon Cho; Seo, Hee Rha; Ja, June Jang; Ro, Jae Y.; Sang, Woo Juhng; Choi, Chan.

In: Journal of Korean medical science, Vol. 22, No. 2, 01.04.2007, p. 305-310.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma

AU - Yoo, Duk Choi

AU - Ki, Seung Kim

AU - Ryu, Sunhyo

AU - Park, Youngkyu

AU - Nam, Hoon Cho

AU - Seo, Hee Rha

AU - Ja, June Jang

AU - Ro, Jae Y.

AU - Sang, Woo Juhng

AU - Choi, Chan

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Claudin-7 has recently been suggested to be a distal nephron marker. We tested the possibility that expression of claudin-7 could be used as a marker of renal tumors originating from the distal nephron. We examined the immunohistochemical expression of claudin-7 and parvalbumin in 239 renal tumors, including 179 clear cell renal cell carcinoma (RCC)s, 29 papillary RCCs, 20 chromophobe RCCs, and 11 renal oncocytomas. In addition, the methylation specific-PCR (MSP) of claudin-7 was performed. Claudin-7 and parvalbumin immunostains were positive in 3.4%, 7.8% of clear cell RCCs, 34.5%, 31.0% of papillary RCCs, 95.0%, 80.0% of chromophobe RCCs, and 72.7%, 81.8% of renal oncocytomas, respectively. The sensitivity and specificity of claudin-7 in diagnosing chromophobe RCC among subtypes of RCC were 95.0% and 92.3%. Those of parvalbumin were 80.0% and 88.9%. The expression pattern of claudin-7 was mostly diffuse in chromophobe RCC and was either focal or diffuse in oncocytoma. All of the cases examined in the MSP revealed the presence of unmethylated promoter of claudin-7 without regard to claudin-7 immunoreactivity. Hypermethylation of the promoter might not be the underlying mechanism for loss of its expression in RCC. Claudin-7 can be used as a useful diagnostic marker in diagnosing chromophobe RCC and oncocytoma.

AB - Claudin-7 has recently been suggested to be a distal nephron marker. We tested the possibility that expression of claudin-7 could be used as a marker of renal tumors originating from the distal nephron. We examined the immunohistochemical expression of claudin-7 and parvalbumin in 239 renal tumors, including 179 clear cell renal cell carcinoma (RCC)s, 29 papillary RCCs, 20 chromophobe RCCs, and 11 renal oncocytomas. In addition, the methylation specific-PCR (MSP) of claudin-7 was performed. Claudin-7 and parvalbumin immunostains were positive in 3.4%, 7.8% of clear cell RCCs, 34.5%, 31.0% of papillary RCCs, 95.0%, 80.0% of chromophobe RCCs, and 72.7%, 81.8% of renal oncocytomas, respectively. The sensitivity and specificity of claudin-7 in diagnosing chromophobe RCC among subtypes of RCC were 95.0% and 92.3%. Those of parvalbumin were 80.0% and 88.9%. The expression pattern of claudin-7 was mostly diffuse in chromophobe RCC and was either focal or diffuse in oncocytoma. All of the cases examined in the MSP revealed the presence of unmethylated promoter of claudin-7 without regard to claudin-7 immunoreactivity. Hypermethylation of the promoter might not be the underlying mechanism for loss of its expression in RCC. Claudin-7 can be used as a useful diagnostic marker in diagnosing chromophobe RCC and oncocytoma.

UR - http://www.scopus.com/inward/record.url?scp=34248538116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248538116&partnerID=8YFLogxK

M3 - Article

C2 - 17449941

AN - SCOPUS:34248538116

VL - 22

SP - 305

EP - 310

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -